DC
NVO

Dantai Capital’s Novo Nordisk NVO Stock Holding History

Dantai Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.29M Hold
27,600
– – 4.17% 8
2024
Q2 		$3.94M Hold
27,600
– – 4.43% 7
2024
Q1 		$3.54M Hold
27,600
– – 4.1% 8
2023
Q4 		$2.86M Buy
27,600
+6,800
+33% +$672K 3.61% 9
2023
Q3 		$1.89M Buy
20,800
+12,800
+160% +$1.13M 4.06% 11
2023
Q2 		$647K Buy
+8,000
New +$654K 1.04% 14

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dantai Capital's NVO Position: Q3 2024 in Review

Dantai Capital held its Novo Nordisk (NVO) position steady in Q3 2024 at 27,600 shares worth $3.29M. The position accounts for 4.17% of the portfolio, ranked #8.

Dantai Capital first reported a position in NVO in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.94M in Q2 2024. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Dantai Capital held 27,600 shares of Novo Nordisk worth $3.29M as of Q3 2024.
  • Dantai Capital left its Novo Nordisk share count unchanged in Q3 2024.
  • Novo Nordisk made up 4.17% of Dantai Capital's portfolio in Q3 2024, its #8 holding.
  • Dantai Capital first reported a position in Novo Nordisk in Q2 2023 and has held it in 6 quarters since.
  • Dantai Capital's Novo Nordisk position peaked at $3.94M in Q2 2024.
  • 1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Dantai Capital's 13F filing for Q3 2024, filed 4 Dec 2024.